Pittsburgh plasma p‐tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer's disease in the community

Documenti analoghi

• Technical and clinical validation of a novel plasma p‐tau217 assay: evaluation in real world population‐based and racially‐diverse cohorts
  di: Anuradha Sehrawat, et al.
  Pubblicazione: (2024)
• Blood biomarker profiles in autopsy‐diagnosed carriers of different PSEN1 mutations relative to sporadic Alzheimer’s disease and controls
  di: Tara K Lafferty, et al.
  Pubblicazione: (2024)
• Histological evaluation of phospho‐epitopes within the core region of soluble and fibrillar tau
  di: Eric E Abrahamson, et al.
  Pubblicazione: (2024)
• Diagnostic Performance of Plasma Phospho‐tau217 for Alzheimer's Disease in a Large Memory Clinic Cohort
  di: Anuradha Sehrawat, et al.
  Pubblicazione: (2025)
• Utilization of plasma Aβ and p ‐tau217 in predicting Aβ accumulation in PET A‐ non‐demented participants
  di: Alexandra Gogola, et al.
  Pubblicazione: (2025)